Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.04B
Enterprise Value3.94B
P/E Ratio-5.21
PEG Ratio0.25
Price/Sales Ratio3.54
Price/Book Ratio8.12
Enterprise/Revenue5.02
Enterprise/EBITDA-10.68

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.69
Operating Margin-0.62
AD

Management Effectiveness

Return On Assets-0.18
Return On Equity-1.24

Income Statement

Revenue900.84M
Revenue/Share1.53
Gross Profit264.37M
EBITDA-127.85M
Net Income-287.37M
Diluted EPS-0.72

Balance Sheet

Total Cash33.65M
Total Cash/Share0.08
Total Debt936.4M
Total Debt/Equity3.51
Current Ratio0.44
Book Value Per Share0.79

Price History

52-Week Change-44.18
52-Week High10.32
52-Week Low5.15
Moving Average 50 Days5.66
Moving Average 200 Days6.22

Statistics

Average Volume898,117
Shares Outstanding400.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.07
Last Split FactorN/A
Last Split DateN/A
AD